Drug-Drug Interaction Study of Vesatolimod in Adults With HIV-1 Who Have Very Low or Undetectable Virus Levels

Stopped Sponsor's decision to change the clinical development plan of this molecule. This decision is not based on efficacy or safety concerns.

Conditions

• Human Immunodeficiency Virus Type 1 (HIV-1) Infection

Interventions

• DRUG: Vesatolimod
• DRUG: Cobicistat
• DRUG: Voriconazole
• DRUG: Rifabutin

Sponsor

Gilead Sciences